Biosante Pharmaceuticals Inc (NASDAQ:BPAX)
CAPS Rating:
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
The Official Website of the Long-Term Investor
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
OMG, BPAX has run up 40% since i initiated my red thumb, and it has run on complete fluff. This company is in the tank ever since the recent CRL, and if they try to climb out, I believe shareholders will be substantially diluted. Short-term, I'm obviously effed and I expect more Seeking Alpha BS articles in the near future. Long-term this stock is coming down. Way down.
NEW YORK, Feb. 9, 2012 -- /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at BioSante Pharmaceuticals, Inc. ("BioSante" or the "Company") (Nasdaq: BPAX).